|
29 May 2012 |
Genzyme and Isis Announce Filing of U.S. NDA for KYNAMRO (mipomersen sodium) in Homozygous Familial Hypercholesterolemia
|
|
24 May 2012 |
RetroSense Therapeutics Completes pre-IND Meeting for RST-001
|
|
23 May 2012 |
Senesco’s SNS01 is a Potent Regulator of Programmed Cell Death and Tumor Growth in Murine Models of Multiple Myeloma
|
|
22 May 2012 |
Mirna Therapeutics Presents Updates on Development Program for Lead Therapeutic Candidate
|
|
18 May 2012 |
Further Analysis Reveals Double Digit Hair Growth in RepliCel's First-in-man Clinical Trial
|
|
18 May 2012 |
World's First Approved Stem Cell Drug; Osiris Receives Marketing Clearance from Health Canada for Prochymal
|
|
17 May 2012 |
Ceregene Parkinson's Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
|
|
17 May 2012 |
Medgenics Receives FDA Clearance to Commence Phase IIb Trial of EPODURE for Sustained Anemia Treatment in Dialysis Patients
|
|
17 May 2012 |
StemCells, Inc. Reports Positive Interim Safety Data From Spinal Cord Injury Trial
|
